ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer.
Reese JM, Suman VJ, Subramaniam M, Wu X, Negron V, Gingery A, Pitel KS, Shah SS, Cunliffe HE, McCullough AE, Pockaj BA, Couch FJ, Olson JE, Reynolds C, Lingle WL, Spelsberg TC, Goetz MP, Ingle JN, Hawse JR.
Reese JM, et al.
BMC Cancer. 2014 Oct 7;14:749. doi: 10.1186/1471-2407-14-749.
BMC Cancer. 2014.
PMID: 25288324
Free PMC article.